1. Home
  2. NX vs ESPR Comparison

NX vs ESPR Comparison

Compare NX & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

N/A

Current Price

$17.11

Market Cap

797.0M

Sector

Industrials

ML Signal

N/A

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

N/A

Current Price

$3.04

Market Cap

793.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NX
ESPR
Founded
1927
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
797.0M
793.7M
IPO Year
2008
2013

Fundamental Metrics

Financial Performance
Metric
NX
ESPR
Price
$17.11
$3.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$28.00
$8.25
AVG Volume (30 Days)
493.5K
3.4M
Earning Date
01-01-0001
04-02-2026
Dividend Yield
1.84%
N/A
EPS Growth
N/A
86.21
EPS
N/A
N/A
Revenue
$1,837,641,000.00
$332,314,000.00
Revenue This Year
$3.18
$27.35
Revenue Next Year
$2.27
N/A
P/E Ratio
N/A
N/A
Revenue Growth
43.81
185.66
52 Week Low
$11.04
$0.73
52 Week High
$22.90
$4.18

Technical Indicators

Market Signals
Indicator
NX
ESPR
Relative Strength Index (RSI) 27.59 41.62
Support Level $16.09 $2.36
Resistance Level $19.88 $3.02
Average True Range (ATR) 0.89 0.17
MACD -0.66 -0.06
Stochastic Oscillator 7.41 34.93

Price Performance

Historical Comparison
NX
ESPR

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: